Percutaneous Pulmonary Valve Implantation after Endocarditis of Contegra® Valved Conduit: A Case Report

Cortese, Bernardo; Palma, Gaetano Di; Giordano, Raffaele; Russolillo, V.; Vosa, Carlo

doi:10.1055/s-0030-1250214

Cited by 4 publications

(5 citation statements)

References 6 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chronic right ventricle overload is associated with dysfunction and sudden death. Percutaneous pulmonary valve implantation improves RVOT hemodynamic and delays surgery by prolonging the conduit lifespan [25]. Procedural results are excellent with a 6% procedural complication rate in specialized centres.…”

Section: Discussionmentioning

confidence: 99%

MR and CT imaging of pulmonary valved conduits in children and adolescents: normal appearance and complications

et al. 2014

View full text Add to dashboard Buy / Rent full text

show abstract

Section: Discussionmentioning

confidence: 99%

MR and CT imaging of pulmonary valved conduits in children and adolescents: normal appearance and complications

et al. 2014

View full text Add to dashboard Buy / Rent full text

show abstract

“…[14,15,17,19,20,24,26,37,50,52,53,55,57,66,67,69,80,85,87,89] Bicuspid aortic valve was observed in 50.0% of these studies, [15,17,19,52,57,69,80,85,87,89] followed by ventricular septal defect (VSD) (20.0%) [20,37,53,76] and tetralogy of Fallot (15.0%). [24,55,66] A history of some form of infection was found in 21 studies. [16,21,31,36,37,39,41,47,49,52,53,60,63,64,…”

Section: Past Medical History/past Surgical Historymentioning

confidence: 96%

“…The majority of these patients were found to have had an infection of the mouth (57.14%). [16,21,37,41,49,60,63,64,71,73,76,78] A history of invasive procedure was recalled in 37 articles, [17,19,20,22,24,26,28,30,35,37,39,41,42,48-50, 55,57,60,66-70,73,74,76,80-84,88-90] the most being aortic valve replacement or aortic arch repair (45.9%) [8,10,11,15,21,28,30,52,59,61,65,66,68,71,73,80] and dental procedure (32.4%). [22,28,35,39,41,[48][49][50]57,68,81,83] Mitral valve replacement, [39,60,67,90] pulmonary repair or pulmonary artery repair, [24,37,55,…”

Section: Past Medical History/past Surgical Historymentioning

confidence: 99%

“…Five studies, however, demonstrated antibiotic resistance, in particular penicillin, [49,62] aminoglycoside [49] and fluoroquinolone. [41,62] In studies where patients survived the course of treatment, more patients showed clinical improvement after receiving six weeks or more of antibiotic therapy [16,19,21,25,[30][31][32][33][34]38,39,41,[47][48][49][50][51]55,57,62,66,67,71,72,76,80,82,87,89] than patients who received under six weeks of antibiotic therapy, [15,23,24,27,[35][36][37]46,52,53,58,59,61,63,65,…”

Section: Management Of Endocarditismentioning

confidence: 99%

“…,25,29,30,32-34,36,38,39, 41-43,46,48,49,52,53,57-60,64-66,68,69,72,73,75-85, 87-90] While the majority of these studies reported the presence of the bacteria in predominantly native-valves,[14][15][16]18,20,24,25,29,30,[32][33][34]36,38,41,43,46,48,49,52,53,[57][58][59]64,65,68,72,[77][78][79][80][81][83][84][85][87][88][89] 12 of those studies highlighted the association of prosthetic valve endocarditis by Gemella spp [17,19,39,42,60,66,69,73,75,76,82,<...>…”

mentioning

confidence: 99%

See 2 more Smart Citations

Risk Factors and Patient Profile of Infective Endocarditis due to <i>Gemella spp.</i>

Kariyanna

Sutarjono

Ellanti

et al. 2020

AJMCR

View full text Add to dashboard Buy / Rent full text

Background. The diagnosis of infective endocarditis is difficult, especially when it involves atypical organisms. Therefore, our study identified risk factors of infective endocarditis caused by rare pathogen, Gemella spp . Methods. A systematic review was conducted to investigate characteristics of endocarditis patients infected with Gemella spp. using the search term “ Gemella ” and “endocarditis.” Case reports were gathered by searching Medline/Pubmed, Google Scholar, CINAHL, Cochrane CENTRAL, and Web of Science databases. 83 articles were selected for review. Results. Five species of Gemella were identified. Typical patients were males between 31 and 45 years of age. On admission, patients had fever, tachycardia, and normal blood pressure. Common clinical manifestation other than fever included fatigue and weakness, chills and sweating, and nausea, vomiting, diarrhea, and weight changes. One in four reported a history of congenital heart disease, and a recent oral cavity infection. Laboratory tests reveal anemia, leukocytosis, and elevated erythrocyte sedimentation in all age groups, elevated C-reactive protein is observed among adult and geriatric populations only. Mitral and aortic valves were most commonly infected by Gemella spp. . The most common Gemella spp. -susceptible antibiotics were penicillin, vancomycin, cephalosporin, macrolide, and aminoglycosides. However, antibiotic resistance was observed against penicillin, aminoglycoside, and fluoroquinolone. Antibiotic course of at least six weeks resulted in superior clinical improvements than durations under six weeks. Finally, one in two patients underwent valve replacement or repair, with common complications affecting the cardiovascular, neurological, and renal systems. Finally, death occurred in 1 in 8 patients, half of which occurred post-surgical procedure, and the majority occurring equal to or greater than 1 week from admission. Conclusion. Our systematic review highlights the importance of considering rare pathogens, particularly in the presence of predisposing risk factors.

show abstract

Percutaneous Pulmonary Valve Implantation after Endocarditis of Contegra® Valved Conduit: A Case Report

Cited by 4 publications

References 6 publications

MR and CT imaging of pulmonary valved conduits in children and adolescents: normal appearance and complications

MR and CT imaging of pulmonary valved conduits in children and adolescents: normal appearance and complications

Risk Factors and Patient Profile of Infective Endocarditis due to <i>Gemella spp.</i>

Contact Info

Product

Resources

About